Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Spark plug and method of manufacturing the same
Building board for use as a carrier for a surface cladding of ceramic tiles, a stucco, or a trowel mortar, on or in buildings
Buckle member
Electro-optic device and display unit
Switch device
Controlled drug release from dendrimers
Liquid crystal display having a voltage stabilization circuit and driving method thereof
  Randomly Featured Patents
Construction system
Method, software program, and system for ranking relative risk of a plurality of transactions
Junction box for vehicles and method for assembling the same
Vapor phase deposition apparatus
Dental products comprising bone growth enhancing peptide
System and method for obtaining a message type identifier through an in-band modem
Fluid power cylinder with position indicator
CR-39 track etching and blow-up method
Process for the removal of hydrogen sulfide and mercaptans from liquid and gaseous streams
Power circuit